SLC5A2 and cancer: Anti-diabetic drugs, including sulfonylureas, biguanides, thiazolidinediones, sodium-glucose co-transporter-2 (SGLT2) inhibitors, and dipeptidyl-peptidase IV, have been reported to exert beneficial effects in many cancers’ treatment [41].